[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,423,802
  • Shares Outstanding, K 118,613
  • Annual Sales, $ 1,397 M
  • Annual Income, $ 316,890 K
  • EBIT $ 649 M
  • EBITDA $ 741 M
  • 60-Month Beta 0.84
  • Price/Sales 6.54
  • Price/Cash Flow 16.14
  • Price/Book 41.54

Options Overview Details

View History
  • Implied Volatility 35.62% (-0.89%)
  • Historical Volatility 30.58%
  • IV Percentile 29%
  • IV Rank 20.59%
  • IV High 52.70% on 08/05/25
  • IV Low 31.19% on 01/20/26
  • Expected Move (DTE 14) 1.40 (1.77%)
  • Put/Call Vol Ratio 0.20
  • Today's Volume 169
  • Volume Avg (30-Day) 535
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 11,154
  • Open Int (30-Day) 15,071
  • Expected Range 78.05 to 80.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.73
  • Number of Estimates 2
  • High Estimate $1.73
  • Low Estimate $1.72
  • Prior Year $1.47
  • Growth Rate Est. (year over year) +17.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.00 +20.38%
on 06/03/26
79.51 -0.08%
on 07/02/26
+13.17 (+19.87%)
since 06/02/26
3-Month
62.27 +27.59%
on 04/07/26
79.51 -0.08%
on 07/02/26
+14.96 (+23.20%)
since 04/02/26
52-Week
53.33 +48.98%
on 07/03/25
82.22 -3.37%
on 02/09/26
+25.61 (+47.57%)
since 07/02/25

Most Recent Stories

More News
1 Surging Stock for Long-Term Investors and 2 We Brush Off

1 Surging Stock for Long-Term Investors and 2 We Brush Off

ACT : 45.34 (-0.11%)
HALO : 79.45 (+3.17%)
CLMT : 36.42 (-0.03%)
2 Profitable Stocks Worth Your Attention and 1 We Question

2 Profitable Stocks Worth Your Attention and 1 We Question

ADM : 76.79 (+0.23%)
UPST : 34.78 (-2.69%)
HALO : 79.45 (+3.17%)
Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029

SAN DIEGO , June 15, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today confirmed that the Company expects zero to minimal royalty revenue impact...

HALO : 79.45 (+3.17%)
Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today

Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today

HALO : 79.45 (+3.17%)
Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

HALO : 79.45 (+3.17%)
3 Growth Stocks Set to Flourish

3 Growth Stocks Set to Flourish

CECO : 82.15 (-3.97%)
TOST : 28.82 (+0.38%)
HALO : 79.45 (+3.17%)
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

COLL : 37.03 (+3.23%)
TMO : 523.44 (+1.97%)
XRAY : 11.65 (+5.05%)
HALO : 79.45 (+3.17%)
Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

HALO : 79.45 (+3.17%)
HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

HALO : 79.45 (+3.17%)
Halozyme Therapeutics Q1 Earnings Call Highlights

Halozyme Therapeutics (NASDAQ:HALO) reported a sharp increase in first-quarter 2026 revenue and earnings, driven by continued growth in royalties from its ENHANZE drug-delivery platform, and announced...

HALO : 79.45 (+3.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company...

See More

Key Turning Points

3rd Resistance Point 82.10
2nd Resistance Point 80.80
1st Resistance Point 80.13
Last Price 79.45
1st Support Level 78.16
2nd Support Level 76.86
3rd Support Level 76.19

See More

52-Week High 82.22
Last Price 79.45
Fibonacci 61.8% 71.18
Fibonacci 50% 67.78
Fibonacci 38.2% 64.37
52-Week Low 53.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.